Hsbc Holdings PLC Makes New $2.45 Million Investment in Addus HomeCare Corporation $ADUS

Key Points

• HSBC Holdings bought 24,463 shares of Addus HomeCare worth approximately $2.45 million in the second quarter, while institutional investors and hedge funds collectively own 95.35% of the stock.
• Addus HomeCare reported quarterly EPS of $1.73, beating estimates of $1.70, while revenue rose 8% year over year to $377.41 million. Analysts expect approximately $6.30 in full-year EPS.
• Analyst sentiment remains broadly positive, with a consensus rating of “Moderate Buy” and an average price target of $130.88, compared with the stock’s reported price of $115.55.

Hsbc Holdings PLC bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 24,463 shares of the company's stock, valued at approximately $2,446,000. Hsbc Holdings PLC owned approximately 0.13% of Addus HomeCare as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Global Retirement Partners LLC boosted its position in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company's stock valued at $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC increased its position in Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company's stock worth $28,000 after purchasing an additional 136 shares during the last quarter. NFJ Investment Group LLC acquired a new stake in Addus HomeCare during the second quarter worth about $29,000. Acumen Wealth Advisors LLC purchased a new position in Addus HomeCare during the fourth quarter worth about $29,000. Finally, Arax Advisory Partners raised its stake in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company's stock worth $30,000 after purchasing an additional 137 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Heather Brianne Dixon sold 288 shares of the firm's stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by company insiders.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $115.55 on Monday. The company's 50 day simple moving average is $111.95 and its 200-day simple moving average is $102.96. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The company has a market capitalization of $2.16 billion, a price-to-earnings ratio of 20.27, a price-to-earnings-growth ratio of 1.55 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts' consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm had revenue of $377.41 million during the quarter, compared to analysts' expectations of $376.24 million. During the same quarter last year, the company posted $1.49 EPS. The firm's quarterly revenue was up 8.0% on a year-over-year basis. As a group, equities research analysts expect that Addus HomeCare Corporation will post 6.3 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on ADUS. Barclays increased their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research note on Wednesday, July 8th. Citizens Jmp reaffirmed a "market outperform" rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup reiterated a "market outperform" rating on shares of Addus HomeCare in a report on Friday, July 24th. Weiss Ratings upgraded Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, July 9th. Finally, Royal Bank Of Canada raised their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $130.88.

About Addus HomeCare

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source